Christina Shay, PhD

Director, Global Epidemiology and Real World Evidence
Boehringer Ingelheim Pharmaceuticals, Inc.

Poster(s):

• (149) Effects of demographics on outcomes with empagliflozin vs. DPP4i
  Wednesday, October 29, 2025